Stockreport

Compass Therapeutics to Participate in the Guggenheim Securities SMID Cap Biotech Conference

Compass Therapeutics, Inc.  (CMPX) 
PDF BOSTON, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietar [Read more]